UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 44,182 Shares of Maximus, Inc. (NYSE:MMS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 35.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 168,936 shares of the health services provider's stock after purchasing an additional 44,182 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.30% of Maximus worth $12,611,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in MMS. Barclays PLC increased its stake in Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock valued at $15,927,000 after purchasing an additional 126,573 shares in the last quarter. Janney Montgomery Scott LLC increased its position in shares of Maximus by 79.7% in the 4th quarter. Janney Montgomery Scott LLC now owns 5,949 shares of the health services provider's stock valued at $444,000 after buying an additional 2,638 shares in the last quarter. Blue Trust Inc. increased its position in shares of Maximus by 27.2% in the 4th quarter. Blue Trust Inc. now owns 1,666 shares of the health services provider's stock valued at $124,000 after buying an additional 356 shares in the last quarter. KBC Group NV raised its stake in Maximus by 78.1% during the 4th quarter. KBC Group NV now owns 2,905 shares of the health services provider's stock worth $217,000 after buying an additional 1,274 shares during the period. Finally, R Squared Ltd bought a new position in Maximus during the fourth quarter worth about $54,000. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Up 0.8%

MMS stock traded up $0.57 during mid-day trading on Tuesday, hitting $71.77. 339,504 shares of the company were exchanged, compared to its average volume of 563,768. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm has a market cap of $4.04 billion, a P/E ratio of 15.43 and a beta of 0.61. The firm's 50 day simple moving average is $70.09 and its 200 day simple moving average is $71.45. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.57 earnings per share. On average, sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.67%. Maximus's dividend payout ratio is currently 23.86%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Insider Buying and Selling

In other news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director now owns 14,205 shares of the company's stock, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.